CHMP opinions diverging from EMA scientific advice
This article was originally published in Scrip
The European Medicines Agency is taking steps to address the "possibility of decreasing compliance" between its scientific advice and the final opinions of its human drugs evaluation committee, the CHMP.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.
A six-month pilot has been launched in the EU to test new processes for multilingual packaging that allows the use of a reduced text on a medicine’s immediate and outer packaging, subject to agreement by member states.